Rahul Gupta, N Director, Office of National Drug Control Policy, Office of National Drug Control Policy, disclosed 2 transactions | KeyVex Disclosures

KeyVex › Disclosures › Executive-branch trades

KeyVex publishes these public financial disclosure filings as news, free and without registration, under the news-media provision of 5 U.S.C. § 13107(c). Source documents are linked on every entry.

Rahul Gupta, N Director, Office of National Drug Control Policy, Office of National Drug Control Policy, disclosed 2 transactions

2023-02-09 · Executive-branch trades · U.S. Office of Government Ethics (Form 278-T)

2023-01-06 · sale	Kimberly-Clark Corp. — $1,001 - $15,000
2023-01-04 · sale	NIKE, Inc. — $1,001 - $15,000

The complete record

Every field KeyVex holds for this filing, as its API serves it. Nothing is withheld here that the API sells.

owner	self
source	OGE_278T
notified	false
amount max	15000
amount min	1001
filer name	Rahul Gupta
filer type	appointee
report url	https://extapps2.oge.gov/201/Presiden.nsf/PAS+Index/F2056361107CFA928525896F00343EDF/$FILE/Rahul-Gupta-02.09.2023-278T.pdf
scraped at	2026-06-02T23:33:31.611Z
filing date	2023-02-09
amount range	$1,001 - $15,000
filer position	N Director, Office of National Drug Control Policy, Office of National Drug Control Policy
transaction type	sale

Each transaction (2)

ticker	filing id	asset name	transaction date
KMB	oge-278t-rahul-gupta-2023-02-09-2	Kimberly-Clark Corp.	2023-01-06
NKE	oge-278t-rahul-gupta-2023-02-09-1	NIKE, Inc.	2023-01-04

Original filing document